Literature DB >> 7631023

Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions.

J Nyman1, I Turesson.   

Abstract

Accelerated radiotherapy has the potential to increase local control of rapidly growing tumours. To determine the necessary time interval for complete repair of sublethal damage in normal tissue in a clinical situation, we have compared the acute and late skin reactions with 8 and 24 h between fractions, using the same dose per fraction and total dose. Forty-nine breast cancer patients participated in this study, and received bilateral parasternal irradiation to 50 Gy with 2 Gy per fraction as part of their adjuvant postoperative radiotherapy. The time interval between daily fractions was always 8 h on the left field and 24 h on the right, and the total treatment time was 2.5 and 5 weeks, respectively. The acute endpoint was erythema, measured by reflectance spectrophotometry and an acute reaction score for erythema and desquamation. The late endpoint was telangiectasia, scored on an arbitrary scale. The results have also been compared with those in a previously treated group of patients with 4 and 24 h between fractions. The degree of acute reactions was decreased with an 8-h interval compared with 24 h between fractions with the peak acute score as endpoint; no difference was seen with the peak reflectance measurements. The maximal expression occurs approximately 1 week earlier with the accelerated schedule, possibly as a consequence of the reduction of the treatment time. The pattern of the acute reaction for 8 h between fractions is similar to that for 4 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7631023     DOI: 10.1016/0167-8140(95)01525-l

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  The contribution of women to radiobiology: Marie Curie and beyond.

Authors:  Anna Gasinska
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

2.  Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.

Authors:  Søren M Bentzen; John R Yarnold
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-15       Impact factor: 7.038

3.  A Randomized Placebo- Controlled Double Blind Clinical Trial of Quercetin in the Prevention and Treatment of Chemotherapy-Induced Oral Mucositis.

Authors:  Mohammad Mahdi Kooshyar; Pegah Mosannen Mozafari; Maryam Amirchaghmaghi; Atessa Pakfetrat; Parisa Karoos; Mahdokht Rashed Mohasel; Hosein Orafai; Amir Abbas Azarian
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 4.  Cancer concepts and principles: primer for the interventional oncologist-part II.

Authors:  Ryan Hickey; Michael Vouche; Daniel Y Sze; Elias Hohlastos; Jeremy Collins; Todd Schirmang; Khairuddin Memon; Robert K Ryu; Kent Sato; Richard Chen; Ramona Gupta; Scott Resnick; James Carr; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-06-28       Impact factor: 3.464

5.  Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.

Authors:  A Murray Brunt; Duncan Wheatley; John Yarnold; Navita Somaiah; Stephen Kelly; Adrian Harnett; Charlotte Coles; Andrew Goodman; Amit Bahl; Mark Churn; Rada Zotova; Mark Sydenham; Clare L Griffin; James P Morden; Judith M Bliss
Journal:  Radiother Oncol       Date:  2016-04-01       Impact factor: 6.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.